Biocept to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 20, 2023
June 14 2023 - 4:05PM
Business Wire
Biocept, Inc. (Nasdaq: BIOC) (“Biocept” or the “Company”), a
leading provider of molecular diagnostic assays, products and
service, announces that management will present at the Maxim Group
Virtual Healthcare Conference hosted by M-Vest on Tuesday, June 20
at 9:00 a.m. Eastern time (6:00 a.m. Pacific time). Biocept’s
discussion will be hosted by Maxim Group Senior Research Analyst
Michael Okunewitch.
Registration information to become an M-Vest member for access
to the live and archived presentation webcast is posted to Events
& Presentations section of the Biocept website.
About M-Vest
M-Vest is a division of Maxim Group LLC that serves to allows
investors access to investment opportunities online and to provide
a digital community built for issuers, investors, and thought
leaders to share information. The platform provides insights on
current market trends through presentations from innovative
emerging growth companies and commentary from industry thought
leaders via live events and Q&A.
About Biocept
Biocept is a molecular diagnostics company with commercialized
assays for patients with carcinomas or melanomas. Our experts have
spent years working to change the way physicians look at
cerebrospinal fluid in cancer patients. Biocept has developed a
unique, patented methodology to isolate cancer material that is
shed from the primary tumor, such as CSF tumor cells (CSF-TCs) and
cell-free DNA (cfDNA). As such, Biocept is a leading commercial
provider of testing services designed to enable clinicians to
rapidly detect and monitor cancer biomarkers from a cerebrospinal
fluid sample.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230615036633/en/
Investor and Media Contact: Jody Cain, LHA Investor
Relations Jcain@lhai.com, 310-691-7100
Biocept (NASDAQ:BIOC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Biocept (NASDAQ:BIOC)
Historical Stock Chart
From Jul 2023 to Jul 2024